(Q43511907)

24 November 2017

title

Disposition of mesalazine from mesalazine-delivering drugs in patients with inflammatory bowel disease, with and without diarrhoea (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1359629

inflammatory bowel diseases

18 September 2022

main subject

diarrhea

0 references

0 references

author name string

van Schaik A

2

1 reference

24 November 2017

van Tongeren JH

3

1 reference

24 November 2017

M. C. Rijk

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1359629

18 September 2022

A. van Schaik

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1359629

18 September 2022

J. H. van Tongeren

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1359629

18 September 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1359629

18 September 2022

publication date

1 October 1992

1 reference

Scandinavian Journal of Gastroenterology

24 November 2017

published in

1 reference

24 November 2017

volume

27

1 reference

24 November 2017

issue

10

1 reference

24 November 2017

page(s)

863-868

1 reference

An oral preparation to release drugs in the human colon

24 November 2017

cites work

1 reference

https://api.crossref.org/works/10.3109%2F00365529209000155

Influence of intestinal transit time on azo-reduction of salicylazosulphapyridine (Salazopyrin)

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365529209000155

Release of 5-aminosalicylic acid from Pentasa during normal and accelerated intestinal transit time

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365529209000155

Longterm olsalazine treatment: pharmacokinetics, tolerance and effects on local eicosanoid formation in ulcerative colitis and Crohn's colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365529209000155

Role of the intestinal flora in the acetylation of sulfasalazine metabolites

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365529209000155

Kinetics of 5-aminosalicylic acid after jejunal instillation in man.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365529209000155

Metabolism and urinary excretion of 5-amino salicylic acid in healthy volunteers when given intravenously or released for absorption at different sites in the gastrointestinal tract

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365529209000155

Cortisone in ulcerative colitis; final report on a therapeutic trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365529209000155

An index of inflammatory activity in patients with Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365529209000155

Transit through the gut measured by analysis of a single stool

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365529209000155

A new method for studying gut transit times using radioopaque markers

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365529209000155

Disposition of 5-aminosalicylic acid by olsalazine and three mesalazine preparations in patients with ulcerative colitis: comparison of intraluminal colonic concentrations, serum values, and urinary excretion

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365529209000155

10.3109/00365529209000155

21 January 2018

Identifiers

DOI

1 reference

24 November 2017

1 reference